• Publications
  • Influence
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
OBJECTIVE The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classificationExpand
  • 2,493
  • 150
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
BACKGROUND Since anecdotal series and small, prospective, controlled trials suggest that mycophenolate mofetil may be effective for treating lupus nephritis, larger trials are desirable. METHODS WeExpand
  • 660
  • 32
  • PDF
Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry.
OBJECTIVES The present study describes the demographics, mortality, morbidity and recurrence rates of autoimmune-associated congenital heart block (CHB) using information from the Research RegistryExpand
  • 613
  • 28
  • PDF
Combined oral contraceptives in women with systemic lupus erythematosus.
BACKGROUND Oral contraceptives are rarely prescribed for women with systemic lupus erythematosus, because of concern about potential negative side effects. In this double-blind, randomized,Expand
  • 559
  • 27
  • PDF
The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial
Context Clinicians sometimes avoid hormone replacement therapy (HRT) in women with systemic lupus erythematosus (SLE) because they think estrogens activate the disease. Contribution In thisExpand
  • 497
  • 18
  • PDF
Circulating endothelial cells. Biomarker of vascular disease.
Recent research has recognised new populations of non-hematopoietic cells in the blood. One of these, circulating endothelial cells (CECs), often defined by the expression of membrane glycoproteinExpand
  • 355
  • 17
  • PDF
Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry.
OBJECTIVE To extend the information base on cutaneous manifestations of neonatal lupus erythematosus (NLE) with regard to maternal disease, sex of child, onset, localization, influence of UV light,Expand
  • 202
  • 13
Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block: The PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study
Background— Anti-SSA/Ro–associated third-degree congenital heart block is irreversible, prompting a search for early markers and effective therapy. Methods and Results— One hundred twenty-sevenExpand
  • 250
  • 12
  • PDF
Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity
Antibodies to DNA and chromatin drive autoimmunity in systemic lupus erythematosus (SLE). Null mutations and hypomorphic variants of the secreted deoxyribonuclease DNASE1L3 are linked to familial andExpand
  • 156
  • 12
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.
OBJECTIVE To investigate which serologic and clinical findings predict adverse pregnancy outcome in patients with antiphospholipid antibody (aPL) and to test the hypothesis that a pattern of clinicalExpand
  • 254
  • 10